• Cancers of blood, head, neck, breast, kidney, bone, or lung
• Idiopathic thrombocytopenic purpura (ITP)
• Multiple myeloma
• Rhabdomyosarcoma
• Thyroid cancer
• Neuroblastoma

The therapeutic effect of Vinlieva 1mg Injection is to inhibit the growth and spread of cancer cells. It disrupts the formation and function of microtubules, which are structures inside cells that help with cell division and movement. By interfering with microtubule function, this medication can prevent cancer cells from dividing and multiplying and can also cause them to die.

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Vinlieva 1mg Injection Injection and reduce effectiveness by causing undesirable side effects.

• Vinlieva 1mg Injection should be stored at room temperature, between 20°C to 25°C (68°F to 77°F).
• Protected from light.
• Keep it in its original packaging until it is ready to be used.
• Keep out of the reach of children and pets.
• Should be disposed of properly.

Vinlieva 1mg Injection is usually administered intravenous injection (IV) by a healthcare professional in a hospital or clinical setting. It should not be taken orally or applied topically to the skin. If you miss a dose, then do not double the dose to make up for the missed one.

Like all medications, Vinlieva 1mg Injection Injection can cause side effects, although not everyone who takes it will experience them. 

Serious:

• Severe allergic reactions
• Pulmonary toxicity (lung damage)
• Liver toxicity
• Neurotoxicity (damage to the nervous system)
• Tumor lysis syndrome (life-threatening complication in which cancer cells release their contents into the bloodstream)

Common:

• Nausea and vomiting
• Constipation
• Loss of appetite
• Hair loss
• Fatigue
• Muscle weakness
• Numbness or tingling in the hands and feet (peripheral neuropathy)
• Increased risk of infection
• Easy bruising or bleeding
• Mouth sores
• Changes in mood or behavior
• Difficulty sleeping

If you are receiving Vinlieva 1mg Injection, it's important to be proactive in managing your treatment and monitoring your symptoms. Keep a close line of communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Take steps to care for yourself physically and emotionally during treatment, and seek support from loved ones and professionals as needed. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. By being informed and engaged in your treatment, you can help ensure the best possible outcomes and manage any potential risks or complications.

1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707.
2. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.
3. Hospira UK Ltd, Electronic medicines compendium (emc), [Revised on March 2022] [ Accessed on 18 April 2023], https://www.medicines.org.uk/emc/files/pil.1501.pdf
4. Hospira, Inc, US Food and Drug Administration, [Revised on July 2013] [ Accessed on 18th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/071484s042lbl.pdf
5. Jan Skubnik et al; Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics; Biology; Published on 31/08/2021; ; Accessed on 18th April 2023; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468923/